Passage Bio Inc

PASG NASDAQ Santé & Biotech États-Unis US7027121000
5.75 $
0.09 %

Passage Bio Inc se spécialise dans le développement de traitements génétiques pour les maladies rares du système nerveux central.

Performance & Momentum

6 Months 34.99 %
1 Year 38.20 %
3 Years 69.82 %
5 Years 97.62 %

Similar stocks to Passage Bio Inc

Anantys Community

Be the first to share your analysis on Passage Bio Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases